General Cancer News

Get the latest cancer news and research. Sort by cancer type or read the current headlines to learn what’s happening in the science of cancer detection and treatment, as well as healthy living tips for dealing with cancer.

Oct

08

Studies From Loyola University Reveal New Findings On Cervical Cancer

In this recent study, researchers in the United States conducted a study To compare the dose distribution between customized planning (CP) and adopting a single plan (SP) in multifractionated high-dose-rate brachytherapy and to establish predictors for the necessity of CP in a given patient. A total of 50 computed tomography-based plans for 10 patients were evaluated.

Oct

07

Rare Head And Neck Cancer Linked To HPV

An increase in cases of a rare type of head and neck cancer appears to be linked to HPV, or human papillomavirus, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center.

Oct

07

New Anti-Cancer Drug Undergoing Testing

A U.S. Phase 1 clinical trial is under way to determine if a new anti-cancer drug is safe and effective for use in patients with solid cancer tumors. The drug, currently called EP-100, is designed to treat common breast, prostate, endometrial, pancreatic, ovarian, skin and testicular cancers. It is being tested by TGen Clinical Research Services at Scottsdale (Ariz.) Healthcare's Piper Cancer Center.

Oct

06

Scientists Find Cause Of Familial Chordoma

U.S. scientists say they've found a genetic alteration is the cause of familial chordoma, an uncommon bone cancer that also affects the nervous system.

Oct

06

Exercising During Adolescence Helps Reduce Risk Of Brain Tumor In Adulthood

Physical activity in adolescence is associated with a lower risk of developing brain tumors in adulthood, a new study suggests. Exercising later in life, however, didn't seem to matter, according to the study published by HealthDay News on Tuesday.

Oct

06

EDAP To Participate In HIFU Liver Cancer Trial

EDAP TMS SA, the global leader in therapeutic ultrasound, announced today that the French regulatory organization AFSSAPS has authorized a Phase I clinical study to evaluate High Intensity Focused Ultrasound (HIFU) technology in patients with metastatic liver cancer. HIFU has the potential to assist with liver ablations and reduce bleeding during surgery.

Oct

06

Cryo-Cell International's Stem Cell Research And Development Helps The Fight Against Breast Cancer

Cryo-Cell International, a global leader in stem cell innovation, is proud to be making progress in the fight against breast cancer through research and development using stem cells from menstrual blood. In honor of National Breast Cancer Awareness Month, Cryo-Cell is supporting Susan G. Komen for the Cure(R) through C'elle (R), the company's service which enables women to collect and cryopreserve stem cells from their menstrual blood.

Oct

06

A Step Toward Curing Cancer: Malfunctioning Enzyme Allows Tumor Growth

Discoveries by Nobel laureate Carol W. Greider and her colleagues have led to advances toward potential cures or treatments for certain types of cancer, and for a growing list of diseases rooted in malfunctions of the DNA-protecting enzyme, called telomerase, that she discovered.

Oct

05

Novel Breast Tissue Feature May Predict Woman's Cancer Risk

Mayo Clinic researchers have found that certain structural features within breast tissue can indicate a woman's individual cancer risk. The findings appear online today in the Journal of Clinical Oncology.

Oct

05

Wistar Researchers Identify Gene That Regulates Breast Cancer Metastasis

Researchers at The Wistar Institute have identified a key gene (KLF17) involved in the spread of breast cancer throughout the body. They also demonstrated that expression of KLF17 together with another gene (Id1) known to regulate breast cancer metastasis accurately predicts whether the disease will spread to the lymph nodes. Previously, the function of KLF17 had been unknown.

Page(s): Prev 12...14 15 16 17 18 19 20 ...14941495 Next 

We care about your feedback. Let us know how we can improve your CancerCompass experience.